Acadia Pharmaceuticals | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
Acadia Pharmaceuticals USD 243.83M 19.91M 2025-06
ALKERMES USD 257.77M 462K 2025-06
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Corcept Therapeutics USD 191M 36.19M 2025-06
Cytokinetics 66.77M 165.03M 2025-06
Eisai JPY 160.05B 12.42B 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
Incyte USD 1.14B 151.67M 2025-06
J&J USD 14.6B 816M 2025-03
Moderna USD 18M 1000K 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Pfizer USD 10.88B 248M 2025-06
Prothena -59001000 66.45M 2024-09
PTC Therapeutics USD 163.39M 999.84M 2025-06
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
Ultragenyx Pharmaceutical USD 143.49M 32.86M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06


Acadia Pharmaceuticals سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.